Search Results

Join NCF for Apr2026. Explore event details, dates, times, and discover opportunities to connect, learn, and get involved. < Back to the upcoming events page https://www.youtube.com/watch?v=x-7k7GDS2CU Some Topics Covered: Neuroendocrine Cancer, Newly Diagnosed Download Presentation Slides >>> ABOUT Being newly diagnosed with neuroendocrine cancer can feel overwhelming. Many patients find themselves asking, “What exactly is neuroendocrine cancer, and how is it different from other cancers?” This webinar is designed to bring clarity, reassurance, and guidance during one of the most confusing stages of the neuroendocrine cancer journey. Join Dr. Osama MoSalem, medical oncologist at St. Luke’s in Kansas City , for a clear and compassionate overview of what every newly diagnosed NET patient should know. Dr. MoSalem will explain what neuroendocrine cancer is, why it behaves differently from more common cancers, and how its unique features influence diagnosis and treatment. This session will walk you through the most important early concepts, including: Grade and stage: what they mean and why they matter Key tests and scans used at diagnosis Treatment pathways , including when to consider surgery, medications, targeted therapies, radioligand therapy, or clinical trials Essential questions to ask your care team Practical first steps to help you feel more prepared and empowered Whether you’re newly diagnosed, supporting a loved one, or simply trying to better understand this disease, this webinar will provide a solid foundation to help you make informed decisions with greater clarity and confidence. ABOUT DR. OSAMA MOSALEM Medical Oncologist St. Luke's Health System Kansas City Osama MoSalem, MD is a board-certified hematologist and medical oncologist with Saint Luke’s Cancer Specialists in Kansas City, MO where he specializes in the care of adults with gastrointestinal (GI) cancers including neuroendocrine tumors. In addition to caring for patients, Dr. MoSalem has been involved in clinical research primarily focused on gastrointestinal cancers, neuroendocrine tumors and precision oncology. Dr MoSalem earned his medical degree from Cairo University, Egypt, residency training in internal medicine at Michigan State University, followed by fellowship training at the Mayo Clinic College of Medicine and Science in Jacksonville, Florida. Outside of medicine, Dr. MoSalem enjoys staying active, playing soccer, and spending time with his family. THANKS TO OUR SPONSORS T he opinions expressed by the guest presenters, as well as the questions asked by the audience, have not been created or suggested by the Neuroendocrine Cancer Foundation or the sponsors of this program. The Neuroendocrine Cancer Foundation does not endorse or promote any of the views, opinions or information provided in this presentation. Audience members should not rely on the opinions or information expressed by the guest presenter and should seek guidance and direction from their own medical advisors regarding any choices they make about their health or treatments.

Join NCF for Feb2025. Explore event details, dates, times, and discover opportunities to connect, learn, and get involved. < Back to the upcoming events page https://www.youtube.com/watch?v=wgEoFAQ7lp8 ABOUT Learn the latest in genetics and genomics for neuroendocrine cancers from medical oncologist Dr. Kimberly Perez from Dana Farber Cancer Institute (DFCI) in Boston, Massachusetts. Dr. Perez has expertise in hereditary cancer syndromes and deciphers the topics of genetics and genomics. ABOUT DR. PEREZ Kim Perez, MD Medical Oncologist D ana Farber Cancer Institute (DFCI) Dr. Kimberly Perez, MD is a member of the Dana-Farber Cancer Institute/Harvard Cancer Center Gastrointestinal Oncology and Cancer Genetics and Prevention disease centers. She is a Senior Physician in Medical Oncology at Dana-Farber Cancer Institute, an Associate Physician in Medical Oncology at Brigham and Women’s Hospital, co-Director of the DFCI Gastrointestinal Clinical Trials program, and an Assistant Professor of Medicine at Harvard Medical School. She received her undergraduate training at Georgetown University in Washington DC and received her medical doctorate from George Washington University in Washington DC. She completed her residency and fellowship training at Rhode Island Hospital in 2010. After completing her fellowship, she joined the medical faculty at Warren Alpert School of Medicine at Brown University and served as a Gastrointestinal Oncologist at the Comprehensive Cancer Center at Rhode Island Hospital. She joined the faculty at the Dana-Farber Cancer Institute in 2015 as a medical oncology physician-scientist who provides patient care and conducts clinical research of novel therapies for patients diagnosed with gastrointestinal cancers and inherited cancer syndromes. Since she joined the faculty, she was designated a Hale Family Center for Pancreatic Cancer Research Clinical Investigator and has developed and led investigator-initiated bench to clinic multi-institutional clinical trials for patients with pancreatic adenocarcinoma. Within the Neuroendocrine and Carcinoid program, she has led multi-institutional clinical trials, translational efforts, and served and led national therapeutic guideline efforts. Dr. Perez is a medical oncology physician-scientist who provides patient care and conducts clinical research of novel therapies for patients diagnosed with gastrointestinal cancers and associated hereditary cancer syndromes. Since she joined the faculty at Harvard Medical School and the Dana-Farber Cancer Institute in 2015, she has developed and led investigator-initiated clinical trials investigating novel therapies for patients with pancreatic adenocarcinoma and neuroendocrine tumors. The opinions expressed by the guest presenters, as well as the questions asked by the audience, have not been created or suggested by LACNETS or the sponsors of this program. LACNETS does not endorse or promote any of the views, opinions or information provided in this presentation. Audience members should not rely solely on the opinions or information expressed by the guest presenter and should seek guidance and direction from their own medical advisors regarding any choices they make about their health or treatments.

Join NCF for Zeal. Explore event details, dates, times, and discover opportunities to connect, learn, and get involved. < Back to the upcoming events page REGISTER Location CinemaWest Beach Cities 4DX, ScreenX & Giant Screen with Laser831 S Nash StEl Segundo, CA 90245 Parking The open lot behind the cinema is the closest, free parking as is the structure attached to it. There is handicapped parking in both and a ramp from the first level of the structure to the theater entrance/patio. Event Schedule & Comfort Tips Saturday’s forecast in El Segundo is a high of 74°F and a low of 59°F . The Mix & Mingle portion of the event will take place outdoors on Pink’s Patio, so we recommend bringing a light layer as the evening cools, and the theater may be cooler inside. 2:30 PM - 3:30 PM – Light savory & sweet bites served on Pink's Patio outside the theater 3:45 PM – Final arrival for screening & last chance to grab your concessions 4:00 PM – Zeal for Life Introduction by Rain Bennett & Screening (90 minutes) 5:30 PM – 'Continuing the Conversation' - Q&A With Dr. Aman Chauhan, Lisa Yen, Rain Bennett, and Dusty Hurley Check-In Please check in at the Neuroendocrine Cancer Foundation registration table when you arrive and be sure to pick up your complimentary Popcorn & Soda/Water Voucher. Regrets If you're unable to make it, please email Heather Davis at Heather@NCF.net . For additional questions, please contact Heather@NCF.net . We look forward to sharing this meaningful afternoon with you. ABOUT Join the Neuroendocrine Cancer Foundation on Saturday afternoon, March 7th, for a special screening of Zeal for Life . To see firsthand what makes those living with neuroendocrine cancer, the experts who treat them, and their caregivers - zealous. Optimism, determination, and wholehearted dedication collectively contribute to longevity and living with zeal! Coping and navigating a cancer diagnosis can be daunting and fraught with overwhelm and misunderstanding, but in this film we take a moment to appreciate when gaps are bridged and connections made to exponentially affect change. This documentary focuses on how patients & caregivers, medical experts and patient advocacy organizations work collectively to better navigate and manage neuroendocrine cancer. The Carcinoid Cancer Foundation recognized this need nearly 60 years ago. For decades, CCF has connected patients with physicians who know and appreciate neuroendocrine tumors. They made evidence-based education accessible to physicians and patients alike. Through many avenues and efforts, CCF has driven awareness, study and understanding of this uncommon disease. This poignant and illuminating film delves into the lives of individuals and families navigating the insidious realm of Neuroendocrine Cancer, or Neuroendocrine Tumor (NET)—an uncommon and notoriously complex treatment, often misdiagnosed or diagnosed after metastasis. Through intimate interviews and compelling spotlight the extraordinary resilience of NET patients, caregivers and the experts who care for them is captured. THANKS TO OUR SPONSORS T he opinions expressed by the guest presenters, as well as the questions asked by the audience, have not been created or suggested by the Neuroendocrine Cancer Foundation or the sponsors of this program. The Neuroendocrine Cancer Foundation does not endorse or promote any of the views, opinions or information provided in this presentation. Audience members should not rely on the opinions or information expressed by the guest presenter and should seek guidance and direction from their own medical advisors regarding any choices they make about their health or treatments.

Join NCF for Oct2025. Explore event details, dates, times, and discover opportunities to connect, learn, and get involved. < Back to the upcoming events page https://www.youtube.com/watch?v=uCJWd8VLNsQ ABOUT A neuroendocrine cancer diagnosis can bring emotional, mental, and psychological challenges that are just as difficult as the physical ones. Join licensed clinical psychologist Dr. Karen Kersting from the Medical College of Wisconsin for a supportive discussion on Coping with Neuroendocrine Cancer: Managing Distress, Worry & Grief. She will offer insights and practical strategies to help patients and caregivers navigate the full emotional and psychological impact of living with NETs. ABOUT KAREN "REN" KERSTING Karen “Ren” Kersting, Ph.D. (she/her) Assistant Professor/Clinical Psychologist Medical College of Wisconsin Surgery/Surgical Oncology Karen Kersting, PhD, is a licensed clinical psychologist who provides counseling and psychotherapy to patients treated by surgeons in the Division of Surgical Oncology at the Medical College of Wisconsin. She completed an undergraduate degree in Journalism at the University of Wisconsin—Madison, a PhD in Counseling Psychology at Virginia Commonwealth University in Richmond, VA, and a postdoctoral fellowship in clinical health psychology at the Dayton Veterans Administration Medical Center in Dayton, OH. She joined the faculty of MCW in 2016. Dr. Kersting’s research interests include the development and assessment of integrated psychosocial services for people coping with cancer diagnosis and treatment, with an emphasis on patients diagnosed with cancer of the pancreas. Additionally, her work aims to highlight issues related to social determinants of health and Acceptance and Commitment Therapy interventions. SUBMIT YOUR QUESTIONS Submit your non-case specific questions for Dr. Kersting. T he opinions expressed by the guest presenters, as well as the questions asked by the audience, have not been created or suggested by the Neuroendocrine Cancer Foundation or the sponsors of this program. The Neuroendocrine Cancer Foundation does not endorse or promote any of the views, opinions or information provided in this presentation. Audience members should not rely on the opinions or information expressed by the guest presenter and should seek guidance and direction from their own medical advisors regarding any choices they make about their health or treatments. THANKS TO OUR SPONSORS

Join NCF for NCD2025. Explore event details, dates, times, and discover opportunities to connect, learn, and get involved. < Back to the upcoming events page WATCH THE RECORDING HERE Read highlights from the event in this blogpost >>> The 2025 NET Cancer Day Symposium was a collaboration between the Neuroendocrine Cancer Foundation and the Sylvester Comprehensive Cancer Center, part of UHealth – University of Miami Health System, in Miami, Florida, held on Sunday, November 9th. ABOUT Hear presentations from local NET experts and stories from those in the neuroendocrine cancer community. Learn about the latest in surgery, medical treatments, PRRT, symptom management, and clinical trials. Ask questions during the live question and answer sessions. Find out how you can spread awareness about neuroendocrine cancer. Post-Event Reception. This event is made possible by the generosity of donors and sponsors. SPEAKER BIOS LOCATION The Robert and Judi Prokop Newman Alumni Center 6200 San Amaro Dr., Coral Gables, FL 33146 AGENDA Download the program >>> *Subject to change. Please check back closer to the event for the most accurate agenda. Time Topic Speaker 8:30 - 9 AM Registration & Breakfast 9 - 9:10 AM Welcome Neuroendocrine Cancer Foundation Team & Dr. Aman Chauhan 9:10 - 9:25 AM Demystifying Clinical Trials Taymeyah Al-Toubah 9:25 - 9:40 AM Role of Surgery in NETs Dr. Jashodeep Datta 9:40 - 9:50 AM Liver-Directed Therapy Dr. Lindsay Thornton 9:50 - 10:10 AM Q&A Faculty; Moderated by Dr. Aman Chauhan 10:10 - 10:30 AM Break 10:30 - 10:45 AM Targeted Therapies & Chemotherapy Dr. Udhayvir Grewal 10:45 - 11 AM PRRT for NETs Dr. Boris Naraev 11 - 11:15 AM Managing Side Effects of Systemic Therapy Dr. Jason Starr 11:15 - 11:30 AM The Latest in Managing Carcinoid Syndrome Dr. Jason Starr 11:30 - 11:45 AM Role of Advocacy in Advancing Care for Neuroendocrine Cancer Dr. Estelamari Rodriquez 11:45 - 12:30 PM Q&A Faculty; Moderated by Dr. Aman Chauhan 12:30 - 1:30 PM Lunch 1:30 - 1:35 PM A NET Patient Journey Aramís Lorié 1:35 - 2:10 PM The Future of NETs: Emerging Therapies & Clinical Trials Dr. Aman Chauhan 2:10 - 2:30 PM Nutrition & Fitness in Cancer Tracy Crane, PhD, RDN 2:30 - 2:45 PM Documentary Trailer 2:45 - 3 PM Closing Neuroendocrine Cancer Foundation Team 3 - 4:30 PM Networking Reception with Live Music Presentation Slides 1_Altoubah.Taymeyah_Demystifying Clinical Trials .pdf Download PDF • 6.51MB 2_Datta-SurgeryNET-110925 Jashodeep Datta .pdf Download PDF • 2.40MB 3_Thorton.Lindsey_Liver Directed Therapy .pdf Download PDF • 1.95MB 4_Grewal_Role of Targeted Therapy & Chemotherapy .pdf Download PDF • 3.29MB 5_Naraev_PRRT for NETs .pdf Download PDF • 3.90MB 6_Starr.Jason_Managing Side Effects of Systemic Therapy_NCF .pdf Download PDF • 337KB 7_Starr.Jason_Carcinoid Syndrome .pdf Download PDF • 401KB 8_Rodriguez.Estelamari _Role of Advocacy in Advancing Care for Neuroendocrine Cancer_ .pdf Download PDF • 7.47MB The opinions expressed by the guest presenters, as well as the questions asked by the audience, have not been created or suggested by NCF or the sponsors of this program. NCF does not endorse or promote any of the views, opinions or information provided in this presentation. Audience members should not rely solely on the opinions or information expressed by the guest presenter and should seek guidance and direction from their own medical advisors regarding any choices they make about their health or treatments. THANKS TO OUR SPONSORS

Join NCF for Oct2024. Explore event details, dates, times, and discover opportunities to connect, learn, and get involved. < Back to the upcoming events page Join us Friday, October 18th at 1:00 PM Pacific to hear renowned liver and pancreas surgeon Dr. Gagandeep “Gaugs” Singh discuss the evolving algorithms in the management of NET liver metastases. Dr. Singh, Chief of Surgical Oncology at City of Hope® Cancer Center in Phoenix, asks the question whether it is prudent to be aggressive surgically, or if it is all about timing and strategy. There will be a live Q&A session immediately following his presentation. Please submit your general questions on surgical interventions of liver metastases into the Slido submission form below. SUBMIT YOUR QUESTIONS *Submit your non-case specific questions below. ABOUT GAGANDEEP SINGH, M.D., F.A.C.S. Internationally renowned liver and pancreas surgeon Gagandeep “Gaugs” Singh, M.D., F.A.C.S., is Chief of Surgical Oncology and Director of Surgical Services at City of Hope® Cancer Center Phoenix. A seasoned health care leader with more than 20 years’ experience building outstanding surgical teams, Dr. Singh is excited to return to Phoenix – where he completed part of his medical training – and to City of Hope, where he spent a decade as the chief of City of Hope Duarte’s surgical oncology program. In the clinic, Dr. Singh takes a thoughtful yet forceful approach to treating cancers of the liver, pancreas and gastrointestinal systems. As a health care leader, he is passionate about empowering teams to achieve their fullest potential. He has been recognized with numerous awards and leadership positions. After beginning his faculty academic career at the Keck School of Medicine at the University of Southern California in Los Angeles, Dr. Singh was appointed director of the Liver and Pancreas Center at the John Wayne Cancer Institute in Santa Monica, California, where he also served as chair of the Cancer Committee. At City of Hope Duarte, Dr. Singh spearheaded the liver and pancreatic cancer programs and led the Division of Surgical Oncology to national recognition. He has been included on multiple lists of “America’s Top Surgeons,” “Best Doctors of America,” “Super Doctors” and “Top Doctors of America.” Dr. Singh earned his medical degree from the Mahatma Gandhi Institute of Medical Sciences in India, before training at multiple internationally renowned cancer centers, including Tata Memorial Hospital and Cancer Center in Bombay, René Descartes University in Paris and the Royal Liverpool University Hospital in the United Kingdom, as well as the Marion Bessin Liver Center at the Albert Einstein College of Medicine in New York, Maricopa Medical Center in Phoenix and the University of Iowa. A board-certified surgeon, diplomate of the American Board of Surgery and fellow of the American College of Surgeons, Dr. Singh is an internationally recognized expert in his field and a member of the National Comprehensive Cancer Network for Hepatobiliary Cancers, the group that sets the guidelines for the standard of care for hepatobiliary cancers. As a researcher, Dr. Singh has written on topics such as complex liver resections for liver metastases, management algorithms for neuroendocrine tumors, vascular reconstructions with difficult pancreatic surgery for pancreatic cancer and advanced robotic surgery. His work on robotic surgery has been presented at the Society of Surgical Oncology, America’s Hepato-Pancreato-Biliary Association, the Society of Laparoscopic & Robotic Surgeons and other national meetings. An innovator at heart, he is in constant pursuit of enhancing the surgical experience and developing technical innovations in liver and pancreatic surgery. He has collaborated with engineers from the California Institute of Technology and Harvey Mudd College and has several invention disclosures and patents to his name. Dr. Singh’s translational research includes projects with molecular biologists, X-ray crystallographers, structural chemists and super-resolution scientists across the City of Hope national system. The opinions expressed by the guest presenters, as well as the questions asked by the audience, have not been created or suggested by LACNETS or the sponsors of this program. LACNETS does not endorse or promote any of the views, opinions or information provided in this presentation. Audience members should not rely solely on the opinions or information expressed by the guest presenter and should seek guidance and direction from their own medical advisors regarding any choices they make about their health or treatments. THANKS TO OUR SPONSORS REGISTER

Join NCF for 2026 Neuroendocrine Cancer Conference Recap. Explore event details, dates, times, and discover opportunities to connect, learn, and get involved. < Back to the upcoming events page 2026 Neuroendocrine Cancer Conference Highlights ABOUT Watch the Virtual 2026 Neuroendocrine Cancer Patient Conference , a free online event designed for individuals living with neuroendocrine cancer , as well as caregivers and families seeking trusted, expert-led information. The 2026 theme, Navigating a Changing Neuroendocrine Cancer Landscape , reflected the rapid advances in neuroendocrine cancer diagnosis, treatment options, and patient care . What the Conference Covered The conference featured expert-led education on key topics in neuroendocrine cancer care, including: Understanding your neuroendocrine tumor diagnosis Overview of treatment options , including systemic and liver-directed therapies Managing treatment side effects The role of imaging and scans in monitoring disease When and how to consider surgery and clinical trials Key insights to help you navigate complex care decisions What the Conference Featured The program brought together: 19 leading NET experts sharing practical, patient-centered insights Real patient stories offering perspective and connection Expert panel discussions on supportive care and treatment decision-making Q & A sessions where specialists answered questions from the community A fully virtual format that allows viewers to pause, rewind, and replay sessions This conference is designed to help patients and caregivers feel more informed, empowered, and confident as they navigate life with neuroendocrine cancer. If you need a primer on neuroendocrine cancer, please watch the The Basics of Neuroendocrine Cancer & Newly Diagnosed Resources playlist . RECORDING Explore the conference recordings below, featuring presentations, panel discussions, patient stories, and expert Q&A sessions covering key topics in neuroendocrine cancer diagnosis, treatment, symptom management, imaging, surgery, liver-directed therapy, PRRT, clinical trials, and supportive care. These recordings are intended to provide education and support for patients, caregivers, families, advocates, and healthcare professionals seeking to better understand the evolving neuroendocrine cancer landscape. Conference Recording Welcome & Introductions https://www.youtube.com/watch?v=7pIzC3KnCNA Understanding Neuroendocrine Cancer: What to Know About My Cancer? Dr. Udhayvir Grewal, Emory Winship Cancer Institute https://www.youtube.com/watch?v=msgIWrtYX7Q Grewal_Navigating an Understanding of Neuroendocrine Cancer .pdf Download PDF • 3.38MB Navigating Scans Dr. Delphine Chen, Fred Hutch Cancer Center https://www.youtube.com/watch?v=Y-P_gGS9Vxc Chen_Navigating Scans .pdf Download PDF • 7.18MB Patient & Caregiver Journey • Sara & Quintin Share Their Story https://www.youtube.com/watch?v=lJFOB00atsY Panel Discussion (1): Navigating Supportive Care Moderator: Dr. Daneng Li, City of Hope Panelists: Dr. Chandana Banerjee, City of Hope Shelia Lindsay, NP, UCSF Victoria Ramirez, LCSW, USC https://www.youtube.com/watch?v=liornTuYWQo Navigating Surgery Dr. Julie Hallet, Sunnybrook Health Sciences Center https://www.youtube.com/watch?v=OlLSLm9lc_I Hallet_Navigating Surgery .pdf Download PDF • 983KB Navigating Liver-Directed Therapy Dr. Michael Soulen, Penn Medicine https://www.youtube.com/watch?v=4V40tYhmyiQ Soulen_Navigating Liver Directed Therapies .pdf Download PDF • 7.88MB Introduction: Navigating Treatments https://www.youtube.com/watch?v=hvLh13wdCz8 Navigating SSAs and Chemotherapy Dr. Guillaume Pegna, Oregon Health & Science University https://www.youtube.com/watch?v=EIHPypAxYG4 Pegna_Navigating SSAs and Chemotherapy .pdf Download PDF • 1.43MB Navigating Targeted Therapies and PRRT Dr. Jennifer Chan, Dana-Farber Cancer Institute https://www.youtube.com/watch?v=mRfIlaDABy4 Chan_Navigating Targeted Therapies and PRRT .pdf Download PDF • 950KB Navigating Clinical Trials Dr. Thorvardur Halfdanarson, Mayo Clinic https://www.youtube.com/watch?v=LpOMU1UPKzI Halfdanarson_Navigating Clinical Trials .pdf Download PDF • 1.33MB Navigating Treatment Sequencing Dr. Pamela Kunz, Yale Medicine https://www.youtube.com/watch?v=-11fqsut90c Kunz_Navigating Treatment Sequencing_Kunz .pdf Download PDF • 2.68MB Navigating Treatment Side Effects Dr. Jason Starr, Mayo Clinic https://www.youtube.com/watch?v=EVkVgSQ7BxU Starr_Navigating Treatment Side Effects .pdf Download PDF • 360KB Panel Discussion (2) - Navigating Treatment Decisions Moderator: Dr. Jaydira Del Rivero, National Cancer Institute Panelists: Chandrikha Chandrasekharan, MD Anderson Cancer Center Dr. Callisia Clarke, Medical College of Wisconsin Dr. Erik Mittra, Oregon Health & Science University https://www.youtube.com/watch?v=BANZAnbSnj8 Patient Journey • Katie Shares Her Story https://www.youtube.com/watch?v=0cxkJvUje40 Q&A with Experts Panel #1 : Dr. Chandrikha Chandrasekharan, MD Anderson Cancer Center Dr. Delphine Chen, Fred Hutch Cancer Center Dr. Pamela Kunz, Yale Medicine Dr. Jaydira Del Rivero, National Cancer Institute Dr. Jason Starr, Mayo Clinic Panel #2 : Dr. Michael Soulen, Penn Medicine Dr. Thorvardur Halfdanarson, Mayo Clinic Dr. Jennifer Chan, Dana-Farber Cancer Institute Dr. Udhayvir Grewal, Emory Winship Cancer Institute https://www.youtube.com/watch?v=lj_JR_EKVFg Conference Closing https://www.youtube.com/watch?v=NZkGFxRQiNA Speaker Bios 2025 Conference The opinions expressed by the guest presenters, as well as the questions asked by the audience, have not been created or suggested by NCF or the sponsors of this program. NCF does not endorse or promote any of the views, opinions or information provided in this presentation. Audience members should not rely solely on the opinions or information expressed by the guest presenter and should seek guidance and direction from their own medical advisors regarding any choices they make about their health or treatments. THANKS TO OUR SPONSORS

Join NCF for Dec2024. Explore event details, dates, times, and discover opportunities to connect, learn, and get involved. < Back to the upcoming events page COMPREHENSIVE GUIDE TO LUNG NEUROENDOCRINE CANCERS This is a 2-session comprehensive guide to lung neuroendocrine cancers. Session A covers Typical Carcinoid and Atypical Carcinoid. Session B covers Large Cell Neuroendocrine Carcinoma and Small Cell Lung Cancer. Watch the session that pertains to your diagnosis. Session A: "Typical Carcinoid & Atypical Carcinoid" https://www.youtube.com/watch?v=owZRDf3ISM4 Session B: "Large Cell Neuroendocrine Carcinoma & Small Cell Lung Cancer" https://www.youtube.com/watch?v=LxXdXMKpaCo Click here for the presentation slides from the above video. ABOUT AMAN CHAUHAN, M.D. Aman Chauhan, MD, earned his medical degree from the Kasturba Medical College in Manipal, Karnataka, India, followed by a dual residency in internal medicine and pediatrics at Louisiana State University in New Orleans. Dr. Chauhan completed his fellowship in hematology and oncology at the University of Kentucky, especially focusing on neuroendocrine tumor (NETs). Additionally, Dr. Chauhan completed a Cancer Therapy Evaluation Program (CTEP) physician externship at the National Cancer institute (NCI) that focused on designing clinical trials and clinical research projects. His clinical interests include treating NETs, including carcinoid tumors, high-grade neuroendocrine carcinomas, and small and large cell neuroendocrine carcinoma. Dr Chauhan leads the University of Miami Neuroendocrine Cancer Program and co-leads Sylvester Theranostics Drug Development Program. He is national principal investigator on several investigator initiated neuroendocrine cancer clinical trials. He has authored over 70 scientific publications and book chapters and has received a career development award from NCI CTEP. Dr Chauhan also serves on AJCC and ASCO NET guideline committees and is an active member of NANETS communication committee. Dr. Chauhan is board certified in internal medicine and medical oncology. He is a member of the American Society of Clinical Oncology as well as the American Association of Cancer Research and the North American Neuroendocrine Tumor Society. 'OUR CANCER STORIES' SURVEY Researchers are currently conducting an international study approved by the NUS Ethics Committee (NUS-IRB-2023-320) to examine the relationship between emotional well-being and recovery for cancer patients. Our Cancer Stories' goal is to gather anonymous insights from individuals (aged 30-70) diagnosed with prostate and lung cancer about their personal experiences. To ensure the success of this research, they are seeking cancer patients willing to share their stories through an online survey with the option of reimbursement of $20 USD upon completion. This is a confidential, online survey that will take about 30 minutes to complete. Survey responses will be used to create stories that will be published on a website called Our Cancer Stories ( www.ourcancerstories.com ). These stories are aimed at providing readers (e.g. cancer patients, survivors, caregivers, and those with loved ones affected by cancer) with information useful in making informed decisions in fighting cancer, while providing comfort and solidarity. Take the Survey The opinions expressed by the guest presenters, as well as the questions asked by the audience, have not been created or suggested by LACNETS or the sponsors of this program. LACNETS does not endorse or promote any of the views, opinions or information provided in this presentation. Audience members should not rely solely on the opinions or information expressed by the guest presenter and should seek guidance and direction from their own medical advisors regarding any choices they make about their health or treatments. THANKS TO OUR SPONSORS

Join NCF for Jan2025. Explore event details, dates, times, and discover opportunities to connect, learn, and get involved. < Back to the upcoming events page https://www.youtube.com/watch?v=Q3ji1Zdo9oE ABOUT Learn from renowned Neuroendocrinologist Dr. David Metz, who discusses neuroendocrine tumors (NETs) found on endoscopy, including gastric, duodenal, colon and rectal NETs. Dr. Metz discusses which NETs can be found on endoscopies and how they are managed and treated. ABOUT DR. METZ David Metz, MD Gastroenterologist University of Pennsylvania School of Medicine Retired Professor CE of Medicine, Perelman School of Medicine, Co-director, GI Physiology Laboratory, Director, Acid Peptic Disorders Specialty Program, Co-director, Penn Program for Swallowing Disorders, Associate Chief for Clinical Affairs, Division of Gastroenterology, Co-director, University of Pennsylvania Neuroendocrine Tumor Program After earning his MD from the University of the Witwatersrand's Medical School, Dr. Metz was a resident at both the Albert Einstein Medical Center and the Johannesburg General Hospital. He went on to complete fellowships at Georgetown University Hospital as well as the National Institutes of Health. Arriving at Penn Medicine in 1993, David Metz, MD, held a variety of leadership roles within the Department of Gastroenterology, including Co-Directorship of the Neuroendocrine Tumor Center and Penn NET Treatment Program. Dr. Metz was previously a staff fellow at the National Institutes of Health, where he performed basic research in pancreatic acinar cell secretion and clinical research in Zollinger-Ellison syndrome. While at Penn Medicine, he served as Chair of the North American Neuroendocrine Tumor Society (NANETS), as a member of the Liaison Committee for Recertification of the American Board of Internal Medicine (American Gastroenterological Association representative), and on the Food and Drug Administration Gastrointestinal Drugs Advisory Committee, among other positions. Dr. Metz's clinical interests at Penn included Zollinger-Ellison syndrome and other acid-peptic conditions, Helicobacter pylori infection, non-steroidal anti-inflammatory drug gastropathy and the diagnosis and management of patients with functional and non-functional neuroendocrine tumors of the pancreas and alimentary tract. An investigator for a series of prominent clinical trials in all of these areas, Dr. Metz has published more than 200 articles on topics of clinical interest and research. He retired in July 2021 after 28 years at Penn Medicine. In 2021 Dr. Metz received the NANETS Lifetime Achievement Award that honors an individual who, over the course of their career, has provided outstanding contributions to neuroendocrine disease management through research, clinical practice or educational initiatives, as well as exceptional leadership in NANETS and dedication to its mission. RESOURCES Listen Read Our Cancer Stories: "Understanding Gastric Neuroendocrine Tumors" "Stages of Gastric Neuroendocrine Tumors" "Hormone Therapy for Gastric Neuroendocrine Tumors" "Types and Grades of Gastric Neuroendocrine Tumors" The opinions expressed by the guest presenters, as well as the questions asked by the audience, have not been created or suggested by LACNETS or the sponsors of this program. LACNETS does not endorse or promote any of the views, opinions or information provided in this presentation. Audience members should not rely solely on the opinions or information expressed by the guest presenter and should seek guidance and direction from their own medical advisors regarding any choices they make about their health or treatments.

Join NCF for Apr29. Explore event details, dates, times, and discover opportunities to connect, learn, and get involved. < Back to the upcoming events page https://www.youtube.com/watch?v=jU1HE38G8JQ ABOUT Learn from Cardiologist and Congenital Heart Disease Specialist, Dr. Prashanth Venkatesh from Cedars-Sinai Smidt Heart Institute in a virtual educational event on carcinoid heart disease. Dr. Venkatesh demystifies the topic and shares the latest developments in its diagnosis and treatment, including a novel minimally invasive approach to replace heart valves damaged by carcinoid heart disease. Prior to the event, we encourage you to watch our February 2024 webinar with Mayo Cardiologist Dr. S Allen Luis at https://www.youtube.com/watch?v=DcewKhYm8uY . Click here for more Carcinoid Heart Disease resources >>> ABOUT DR. PRASHANTH VENKATESH Cardiologist & Congenital Heart Disease Specialist, Cedars-Sinai Smidt Heart Institute Prashanth Venkatesh, MD, FACC is a cardiologist at the Smidt Heart Institute at Cedars-Sinai Medical Center in Los Angeles, California. He is an assistant professor of cardiology at Cedars-Sinai, and also an assistant professor of medicine at the David Geffen School of Medicine at the University of California, Los Angeles. At Cedars-Sinai, he is part of the multidisciplinary neuroendocrine clinic where he cares for patients with carcinoid heart disease. Additionally, Dr. Venkatesh is a specialist adult congenital cardiologist at the Guerin Congenital Heart Program at Cedars-Sinai, and also a member of the echocardiography faculty. He leverages his clinical expertise in these subspecialties to improve care for his patients with carcinoid heart disease. Dr. Venkatesh also is actively involved in clinical research and has authored several first-author publications and book chapters. His research interests include echocardiography and adult congenital heart disease, in addition to outcomes and quality improvement in the contemporary care of carcinoid heart disease. T he opinions expressed by the guest presenters, as well as the questions asked by the audience, have not been created or suggested by the Neuroendocrine Cancer Foundation or the sponsors of this program. The Neuroendocrine Cancer Foundation does not endorse or promote any of the views, opinions or information provided in this presentation. Audience members should not rely on the opinions or information expressed by the guest presenter and should seek guidance and direction from their own medical advisors regarding any choices they make about their health or treatments. THANKS TO OUR SPONSORS

Join NCF for Apr2025. Explore event details, dates, times, and discover opportunities to connect, learn, and get involved. < Back to the upcoming events page https://www.youtube.com/watch?v=JkH2Jsvc1Co Download the Transcript Here >>> ABOUT Learn from internationally-renowned neuroendocrine cancer expert Dr. Edward Wolin in a discussion on the latest in neuroendocrine tumor treatments and understanding how to sequence them. Dr. Wolin has pioneered many of the NET treatments including somatostatin analogues (SSAs, sandostatin and octreotide), mTOR inhibitors (i.e. everolimus), anti-angiogenic drugs (i.e. cabozantinib), and peptide receptor radiotherapy (PRRT, i.e. Lutathera). Join us for an insightful presentation and live question and answer session. ABOUT DR. EDWARD WOLIN DR. Edward Wolin Professor of Medicine, Medical Oncology, Icahn School of Medicine Director, Center for Carcinoid and Neuroendocrine Tumors Tisch Cancer Institute, Mount Sinai Health System Dr. Edward M. Wolin is an internationally renowned authority on neuroendocrine tumors. Dr. Wolin is the Director of the Center for Carcinoid and Neuroendocrine Tumors at the Tisch Cancer Institute at Mount Sinai and Professor of Medicine, Medical Oncology at the Icahn School of Medicine at Mount Sinai. The multidisciplinary Center for Carcinoid and Neuroendocrine Tumors features a robust research program with clinical trials aimed at finding the most effective treatments, including immunotherapy, biologic agents, targeted radiation therapy, and new approaches in molecular imaging for diagnosis. Dr. Wolin has pioneered innovative therapies with novel somatostatin analogs, mTOR inhibitors, anti-angiogenic drugs, and peptide receptor radiotherapy. Prior to joining Mount Sinai, Dr. Wolin was Director of the Neuroendocrine Tumor Program at Montefiore Einstein Cancer Center. Previously, he worked for more than two decades with Cedars-Sinai Medical Center in Los Angeles, where he founded and directed one of the largest Carcinoid and Neuroendocrine Tumor Programs in the country, and subsequently directed the Neuroendocrine Tumor Program at University of Kentucky. Dr. Wolin is also the Co-Medical Director for the Carcinoid Cancer Foundation and is on the Carcinoid Cancer Research Grants Scientific Review Committee for the American Association for Cancer Research. He has published in many prestigious journals, including the New England Journal of Medicine and Journal of Clinical Oncology, and is a reviewer for numerous journals, including Journal of Clinical Oncology, Molecular Cancer Therapeutics, Clinical Cancer Research, and The Lancet Oncology. During Dr. Wolin’s two decades at Cedars-Sinai Medical Center in Los Angeles, he developed a close friendship with LACNETS founder Giovanna Joyce Imbesi. Dr. Wolin was instrumental in the co-founding and development of LACNETS. LACNETS has always been very dear to his heart and he cherishes and honors the memory of Giovanna. Dr. Wolin earned his medical degree from Yale School of Medicine. He completed both his residency in internal medicine and fellowship in medical oncology at Stanford University Hospital. He was also a clinical fellow at the National Cancer Institute of the National Institutes of Health. Dr. Wolin is board certified in internal medicine and medical oncology. T he opinions expressed by the guest presenters, as well as the questions asked by the audience, have not been created or suggested by the Neuroendocrine Cancer Foundation or the sponsors of this program. The Neuroendocrine Cancer Foundation does not endorse or promote any of the views, opinions or information provided in this presentation. Audience members should not rely solely on the opinions or information expressed by the guest presenter and should seek guidance and direction from their own medical advisors regarding any choices they make about their health or treatments. THANKS TO OUR SPONSORS

Join NCF for Jan2026. Explore event details, dates, times, and discover opportunities to connect, learn, and get involved. < Back to the upcoming events page https://www.youtube.com/watch?v=Vb7aH06UWrE Download PowerPoint Slides >>> Some Topics Covered: Types of Functional Neuroendocrine Tumors, Hormone-producing, Carcinoid Syndrome, Insulinoma, Gastrinoma, VIPoma, Zollinger-Ellison syndrome (ZES), Diarrhea, Flushing, Hypoglycemia, Carcinoid Heart Disease, Cushing Syndrome, Somatostatinoma. ABOUT Join us for an easy-to-understand overview of functional neuroendocrine tumors (NETs) with Dr. Jaydira Del Rivero, a medical oncologist and endocrinologist at the National Cancer Institute. Functional NETs can cause the body to produce too many hormones, leading to challenging symptoms such as low blood sugar (often seen in insulinoma), high blood sugar (glucagonoma), carcinoid syndrome (excess serotonin), and other hormone-related issues and symptoms. Dr. Del Rivero will explain what these syndromes are, how they’re diagnosed, and the latest updates in treatment. She will also discuss conditions that can occur because of NETs or their treatments. She will help patients understand why symptoms like hypoglycemia are more common in some NET types. Whether you’re a patient, caregiver, or simply want to better understand functional NETs, this webinar will offer practical, up-to-date information to help you feel more informed and empowered. ABOUT DR. JAYDIRA DEL RIVERO Medical Oncologist & Endocrinologist National Cancer Institute, National Institutes of Health Dr. Del Rivero earned her medical degree from the University of Veracruz in Veracruz, Mexico and completed her internal medicine residency at Woodhull Medical and Mental Health Center/NYU-Langone Medical Center. Dr. Del Rivero completed a fellowship in Endocrinology, Diabetes and Metabolism at The Inter-Institute Endocrinology Training Program (IETP) at the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), The National Institute of Child Health and Human Development (NICHD), and The National Institute of Dental and Craniofacial Research (NIDCR) where she was part of a research team developing clinical trials for pheochromocytoma and paraganglioma. She then joined as Assistant Professor at the Montefiore Einstein Center for Cancer Care (MECCC) where she specialized in endocrine oncology involving thyroid cancer, parathyroid and adrenal tumors, and clinical research for gastroenteropancreatic neuroendocrine tumors. She subsequently completed a second fellowship in medical oncology at the National Cancer Institute (NCI) with a research focus on endocrine malignancies. Dr. Del Rivero is board certified in Internal Medicine, Endocrinology, Diabetes and Metabolism and Medical Oncology. Dr. Del Rivero is a Physician Scientist in the Developmental Therapeutics Branch. She is the Principal Investigator of the Natural History Study for Neuroendocrine Neoplasm and Adrenocortical Cancer to provide the basis of further development of therapeutic interventions, prevention/screening guidelines, endpoints for future clinical trials, and patient reported outcome measures. Dr. Del Rivero’s current efforts is the development of novel treatment approaches and targeted therapies for endocrine malignancies such as advanced gastroenteropancreatic neuroendocrine tumors, adrenocortical cancer and pheochromocytoma/paraganglioma. THANKS TO OUR SPONSORS PRESENTING SPONSOR SPONSORS T he opinions expressed by the guest presenters, as well as the questions asked by the audience, have not been created or suggested by the Neuroendocrine Cancer Foundation or the sponsors of this program. The Neuroendocrine Cancer Foundation does not endorse or promote any of the views, opinions or information provided in this presentation. Audience members should not rely on the opinions or information expressed by the guest presenter and should seek guidance and direction from their own medical advisors regarding any choices they make about their health or treatments.